Subinit

Subinit (Sunitinib Malate) is an oral prescription medication used to treat certain types of cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors. This product is manufactured in the EU and is intended for oral administration only.

Subinit (Sunitinib Malate) is prescribed to manage certain cancers by slowing or stopping their growth. It is commonly used for gastrointestinal stromal tumors and advanced kidney cancer. Patients and caregivers often ask, 'what is Subinit used for' to understand its role in treatment plans.

Subinit (Sunitinib Malate) works by targeting specific proteins in cancer cells to inhibit their growth. Users may experience effects such as fatigue, digestive changes, or skin discoloration. These effects vary and should be monitored by a healthcare professional.

Subinit (Sunitinib Malate) should be handled with care, especially during preparation or administration. Avoid contact with broken tablets and wash hands thoroughly afterward. Keep this medication out of reach of children and pets.

Subinit (Sunitinib Malate) may interact with other medications, including certain antibiotics, antifungals, and herbal supplements. Alcohol and grapefruit products may also affect how this drug works. Always inform your healthcare provider about all medications you are taking.